Skip to content

Study on diabetes remission using weight management program for obesity and type 2 diabetes

Study on diabetes remission using weight management program for obesity and type 2 diabetes - ADDRESS (Asama Dietary Diabetes Remission Study)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035237
Enrollment
40
Registered
2018-12-13
Start date
2019-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Weight management program group: Discontinue diabetes medicine at the start of treatment 3 months from the start: weight loss meal, low calorie diet of about 800 kcal / day 3 months to 6 months: Ph
20%), fat = &lt
25%

Sponsors

Asama General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Men and women aged over 20 years and and under 75 2) Patients from 0 to 10 years after being diagnosed with type 2 diabetes 3) Patients with HbA1c >= 6.6% with diet only during the last 12 months 4) Patients with oral diabetes drug HbA1c >= 6.2% 5) Patients with BMI> 25 kg/m2 and <45 kg/m2 6) Patients for whom consent is documented for participation in this study

Exclusion criteria

Exclusion criteria: 1) Patients who are using insulin 2) Patient with recent HbA1c >= 12.1% 3) Patients with weight loss> 5 kg within the past 6 months 4) Patients with recent eGFR <30 ml/min / 1.73 m2 5) Patients with drug addiction 6) Patients with malignant tumors 7) Patients who developed myocardial infarction within the past 6 months 8) Patients with grade 3 or higher severe heart failure of the New York Heart Association (NYHA) 9) Patients with learning disabilities 10) Patients being treated with antiobesity drugs 11) Patients diagnosed with eating disorders 12) Pregnant women, lactating women and patients with the possibility of being pregnant (intention) 13) Patients who need inpatient treatment due to depression or patients with antipsychotic oral administration 14) Patients participating in other clinical studies 15) Patients judged inappropriate for judgment by doctor's judgment

Design outcomes

Primary

MeasureTime frame
(1) Weight after 6 months from start (weight loss of 10% or more from the start) (2) HbA1c (less than 6.5% HbA1c without diabetes medicine) after 6 months from start

Countries

Japan

Contacts

Public ContactNishimori Eita

Asama General Hospital Diabetes Medicine

eita-nishimori@umin.ac.jp0267-67-2295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026